Palonosetron Hydrochloride | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Palonosetron Hydrochloride
Canada

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Palonosetron Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 22 USDMF, 3 JDMF, 8 EU WC, 4 KDMF, 14 NDC API, 24 Listed Suppliers, $ API Reference Price

41 API Suppliers
22 USDMF
3 JDMF
8 EU WC
4 KDMF
14 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers, 34 FDA Orange Book, 20 Europe, 2 Canada, 6 Australia, 1 South Africa, 21 Listed Dossiers

84 FDF Dossiers
34 FDA Orange Book
20 Europe
2 Canada
6 Australia
1 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE, SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML), POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL, SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML), INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE
SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL
SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Rochem International Inc, 16 SPI Pharma, 7 DKSH, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 9 Microlex e.U, 1 NEWEDGE Overseas, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 22 Roquette, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 20 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Lubricants & Glidants, 16 Thickeners and Stabilizers, 15 Taste Masking, 15 Chewable & Orodispersible Aids, 12 Parenteral, 12 Co-Processed Excipients, 11 Coating Systems & Additives, 11 Film Formers & Plasticizers, 10 Granulation, 8 Empty Capsules, 6 Controlled & Modified Release, 3 Solubilizers, 3 Emulsifying Agents, 2 Coloring Agents, 2 Topical, 2 Rheology Modifiers, 2 API Stability Enhancers, 1 Soft Gelatin

47 Fillers, Diluents & Binders
20 Disintegrants & Superdisintegrants
18 Direct Compression
17 Lubricants & Glidants
16 Thickeners and Stabilizers
15 Taste Masking
15 Chewable & Orodispersible Aids
12 Parenteral
12 Co-Processed Excipients
11 Coating Systems & Additives
11 Film Formers & Plasticizers
10 Granulation
8 Empty Capsules
6 Controlled & Modified Release
3 Solubilizers
3 Emulsifying Agents
2 Coloring Agents
2 Topical
2 Rheology Modifiers
2 API Stability Enhancers
1 Soft Gelatin

DIGITAL CONTENT

62 NEWS #PharmaBuzz

62 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 18 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
18 Finished Drug Prices
10 Annual Reports

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

76 US Patents, 3 Health Canada Patents

76 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 USP, 7 Others

7 USP
7 Others

$ API Ref.Price (USD/KG) : 680,068 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2KNIGHT THERAPEUTICS INC.

filter Active Ingredients Reset all filters

2 All

01 2PALONOSETRON (PALONOSETRON HYDROCHLORIDE)

filter Dosage Form Reset all filters

2 All

01 1CAPSULE

02 1SOLUTION

filter Brand Name Reset all filters

2 All

01 1AKYNZEO

02 1ALOXI

List of Suppliers

Product Main Page

01

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

PALONOSETRON (PALONOSETRON HYDROCHLORIDE)

Brand Name : ALOXI

Dosage Form : SOLUTION

Dosage Strength : 0.25MG/5ML

Packaging : 5ML

Approval Date :

Application Number : 2381710

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

PALONOSETRON (PALONOSETRON HYDROCHLORIDE)

Brand Name : AKYNZEO

Dosage Form : CAPSULE

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number : 2468735

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!